Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16588
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorCheng, AC-
dc.contributor.authorKorman, TM-
dc.contributor.authorRoder, C-
dc.contributor.authorCampbell, A-
dc.contributor.authorMay, MLA-
dc.contributor.authorBlyth, CC-
dc.contributor.authorFerguson, JK-
dc.contributor.authorBlackmore, TK-
dc.contributor.authorRiley, TV-
dc.contributor.authorAthan, E-
dc.date.accessioned2017-02-28T23:49:18Z-
dc.date.available2017-02-28T23:49:18Z-
dc.date.issued2016-04-
dc.identifier.citationInternal Medicine Journal 2016; 46(4): 479-493en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16588-
dc.description.abstractThe incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.en_US
dc.subjectClostridium difficileen_US
dc.subjectFaecal microbiota transplant (FMT)en_US
dc.subjectFidaxomicinen_US
dc.subjectMetronidazoleen_US
dc.subjectTreatmenten_US
dc.subjectVancomycinen_US
dc.titleAustralasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealanden_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternal Medicine Journalen_US
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationInfectious Diseases Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationInfectious Diseases Department, Alfred Health, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationInfection Prevention and Healthcare Epidemiology Unit, Alfred Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationMonash Infectious Diseases, Monash Health, Monash University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationSchool of Medicine, Deakin University, Geelong, Victoria, Australiaen_US
dc.identifier.affiliationGeelong Centre for Emerging Infectious Diseases, Barwon Health, Geelong, Victoria, Australiaen_US
dc.identifier.affiliationInfectious Diseases Department, Princess Margaret Hospital for Children, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australiaen_US
dc.identifier.affiliationInfection Management and Prevention Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australiaen_US
dc.identifier.affiliationSullivan Nicolaides Pathology, Brisbane, Queensland, Australiaen_US
dc.identifier.affiliationSchool of Paediatrics and Child Health, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australiaen_US
dc.identifier.affiliationDepartment of Microbiology, PathWest Laboratory Medicine, Princess Margaret Hospital, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australiaen_US
dc.identifier.affiliationPathology North, NSW Pathology, Wellington South, New Zealanden_US
dc.identifier.affiliationImmunology and Infectious Diseases Unit, John Hunter Hospital, Wellington South, New Zealanden_US
dc.identifier.affiliationUniversities of New England and Newcastle, Newcastle, New South Wales, Australiaen_US
dc.identifier.affiliationLaboratory Services, Wellington Regional Hospital, Wellington South, New Zealanden_US
dc.identifier.affiliationMicrobiology and Immunology, School of Pathology and Laboratory Medicine, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australiaen_US
dc.identifier.affiliationDepartment of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australiaen_US
dc.identifier.affiliationDepartment of Infectious Disease, Barwon Health, Geelong, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27062204en_US
dc.identifier.doi10.1111/imj.13027en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherCampbell, Ainsley-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.